Huahai US, Inc. develops, acquires, licenses, registers, markets, and distributes prescribed generic pharmaceutical products. It offers cardiovascular, CNS, Alzheimer’s, anti-diabetes, and anti-HIV products to the US market. Huahai US, Inc. is a wholly owned subsidiary of Zhejiang Huahai Pharmaceutical Co. Ltd., the first Chinese manufacturer approved by the US FDA in 2007 for manufacturing finished products. It was founded in 2004 and is located in Cranbury, New Jersey.